SARS-CoV-2 Immunization Orchestrates the Amplification of IFNγ-Producing T Cell and NK Cell PersistenceImmunology Published on 2022-02-142022-11-01 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.798813 PMC 바로가기 [Article Type] Immunology
Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individualsSARS-CoV-2에 대한 타액 IgG는 혈청 전환을 나타내며 mRNA 백신 접종 면역 저하된 개인의 혈청 중화와 상관 관계가 있습니다Article Published on 2022-02-112022-09-12 Journal: Med (New York, N.Y.) [Category] [DOI] 10.1016/j.medj.2022.01.001 PMC 바로가기 [Article Type] Article
Effectiveness of mRNA BNT162b2 Vaccine 6 Months after Vaccination among Patients in Large Health Maintenance Organization, IsraelExpedited Published on 2022-02-012022-10-31 Journal: Emerging Infectious Diseases [Category] [DOI] 10.3201/eid2802.211834 PMC 바로가기 [Article Type] Expedited
Pfizer-BioNTech vaccine effectiveness against Sars-Cov-2 infection: Findings from a large observational study in IsraelObservational Study Published on 2022-02-012022-10-05 Journal: Preventive medicine [Category] [DOI] 10.1016/j.ypmed.2021.106947 PMC 바로가기 [Article Type] Observational Study
Virological and Serological Characterisation of SARS-CoV-2 Infections Diagnosed After mRNA BNT162b2 Vaccination Between December 2020 and March 2021Medicine Published on 2022-01-202022-10-31 Journal: Frontiers in Medicine [Category] [DOI] 10.3389/fmed.2021.815870 PMC 바로가기 [Article Type] Medicine
A 2-month field cohort study of SARS-CoV-2 in saliva of BNT162b2 vaccinated nursing home workers Research Published on 2022-01-102022-10-05 Journal: Communications Medicine [Category] [DOI] 10.1038/s43856-021-00067-3 [Article Type] Research
Mucosal immune response in BNT162b2 COVID-19 vaccine recipientsBNT162b2 COVID-19 백신 수혜자의 점막 면역 반응Clinical Trial Published on 2022-01-012022-09-12 Journal: EBioMedicine [Category] [DOI] 10.1016/j.ebiom.2021.103788 PMC 바로가기 [Article Type] Clinical Trial
Longitudinal Analysis of Antibody Responses to the mRNA BNT162b2 Vaccine in Patients Undergoing Maintenance Hemodialysis: A 6-Month Follow-UpMedicine Published on 2021-12-242022-10-31 Journal: Frontiers in Medicine [Category] [DOI] 10.3389/fmed.2021.796676 PMC 바로가기 [Article Type] Medicine
Nasal and Salivary Mucosal Humoral Immune Response Elicited by mRNA BNT162b2 COVID-19 Vaccine Compared to SARS-CoV-2 Natural InfectionArticle Published on 2021-12-182022-10-28 Journal: Vaccines [Category] [DOI] 10.3390/vaccines9121499 PMC 바로가기 [Article Type] Article
Evaluation of antibody response to BNT162b2 mRNA COVID-19 vaccine in patients affected by immune-mediated inflammatory diseases up to 5 months after vaccination백신 접종 후 최대 5개월까지 면역 매개 염증성 질환에 걸린 환자에서 BNT162b2 mRNA COVID-19 백신에 대한 항체 반응 평가Original Article Published on 2021-11-052022-09-12 Journal: Clinical and experimental medicine [Category] [DOI] 10.1007/s10238-021-00771-3 PMC 바로가기 [Article Type] Original Article